Brief: Vistagen Appoints Angel S. Angelov As Chief Medical Officer
19/05/2026 13:50
May 19 (Reuters) - VistaGen Therapeutics Inc VTGN.O: VISTAGEN APPOINTS ANGEL S. ANGELOV, MD, MBA, AS CHIEF MEDICAL OFFICER Source text: ID:nBw24Plq8a Further company coverage: VTGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors